Ítem


Microbial index in spondyloarthritis with and without inflammatory bowel disease

1. Abstract: A 60% of Spondyloarthritic patients have a subclinical low-degree chronic intestinal inflammation and a 7% of them will develop an Intestinal bowel disease. Currently, some studies demonstrate a dysbiosis on ankylosing spondylitis and a common immune disturbance background with intestinal bowel disease. F.Prausnitzii/ E.coli index has demonstrated significant differences between Crohn’s disease and Healthy controls. In this study, we want to know how this microbial index works as a marker on stool samples in patients with Ankylosing spondylitis with and without Intestinal bowel disease. 2. Objectives: To compare the microbial index (concentration of F.prausnitzii and E.coli) on stool sample in two groups of patients with ankylosing spondylitis; those with and without Crohn’s disease. 3. Population: a total of 60 Anti-TNF naïve patients will be included this study. 20 Chron’s disease patients (CDAI >220 low-mild moderate activity), 20 Spondylitis patients without IBD and 20 Spondylitis patients with IBD. 4. Design: Transversal descriptive study

Director: Aldeguer i Manté, Xavier
Castells Cervelló, Xavier
Altres contribucions: Universitat de Girona. Facultat de Medicina
Autor: Mijancos Aguirre, Carolina
Data: novembre 2017
Resum: 1. Abstract: A 60% of Spondyloarthritic patients have a subclinical low-degree chronic intestinal inflammation and a 7% of them will develop an Intestinal bowel disease. Currently, some studies demonstrate a dysbiosis on ankylosing spondylitis and a common immune disturbance background with intestinal bowel disease. F.Prausnitzii/ E.coli index has demonstrated significant differences between Crohn’s disease and Healthy controls. In this study, we want to know how this microbial index works as a marker on stool samples in patients with Ankylosing spondylitis with and without Intestinal bowel disease. 2. Objectives: To compare the microbial index (concentration of F.prausnitzii and E.coli) on stool sample in two groups of patients with ankylosing spondylitis; those with and without Crohn’s disease. 3. Population: a total of 60 Anti-TNF naïve patients will be included this study. 20 Chron’s disease patients (CDAI >220 low-mild moderate activity), 20 Spondylitis patients without IBD and 20 Spondylitis patients with IBD. 4. Design: Transversal descriptive study
Format: application/pdf
Accés al document: http://hdl.handle.net/10256/15674
Llenguatge: eng
Col·lecció: Medicina (TFG)
Drets: Attribution-NonCommercial-NoDerivatives 4.0 International
URI Drets: http://creativecommons.org/licenses/by-nc-nd/4.0/
Matèria: Espondiloartropaties
Spondyloarthropathies
Espondiloartritis anquilosant
Ankylosing spondylitis
Intestins -- Inflamació
Inflammatory bowel diseases
Crohn, Malaltia de
Crohn’s disease
Microbiologia
Intestins -- Microbiologia
Intestines -- Microbiology
Títol: Microbial index in spondyloarthritis with and without inflammatory bowel disease
Tipus: info:eu-repo/semantics/bachelorThesis
Repositori: DUGiDocs

Matèries

Autors